AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06079515 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intraarticular Shoulder Injection
Description: IAI group: The patients were asked to sit on the chair with their hands facing the opposite shoulder, and the transducer was placed slightly below the spina scapula. The humeral head was observed by moving laterally. The injection mixture was applied in-plane with a 22-gauge, 90-mm needle entering the skin at a 45-degree angle and applied to the joint space
Study NCT04630821 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dilute Sodium Hypochlorite solution
Description: Subjects will be treated with the dilute bleach compresses daily for the first 3 weeks of therapy.~While these subjects are undergoing radiation therapy, they will be assessed weekly before the day's compress treatment by a physician investigator on the study team. Subjects will be evaluated and photographs will also be taken at study visits 1-3. The subjects will also complete a subject questionnaire addressing patient-reported outcomes at baseline and each weekly check-in during these two weeks. They will be also interviewed about ease of use and treatment tolerability. Subjects will complete interview questions at the end of the study to determine if they would continue the treatment and any obstacles or barriers.
Study NCT05550285 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: orbital floor recontriction
Description: Guided Calvarial Graft Harvesting vs 3D Printed Titanium mesh
Study NCT06026007 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: advices
Description: each pregnant woman was advices how to elevate her legs and daily positions to elevate edema
Study NCT06026007 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional physical therapy
Description: each pregnant woman was advised about daily routine in addition to circulatory exercise
Study NCT06026007 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acupressure
Description: each pregnant woman was advised about daily routine in addition to acupressure therapy
Study NCT05611099 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dreem 3 System vs WatchPAT One
Description: Dreem 3 System and WatchPAT One will be worn simultaneously during 3 nights by each study participant, in order to compare the TST automatically outputted by both devices.
Study NCT05611099 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usability Questionnaire
Description: After having undergone the 3 nights of measurement, an end of Study Questionnaire will be performed on a separate day to obtain Usability feedback from participants who have undergone simultaneous recordings with the Dreem 3 + WatchPAT devices.
Study NCT04703322 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pexidartinib
Description: 400 mg twice daily for a total daily dose of 800 mg (each capsule contains 200 mg of pexidartinib for oral administration)
Study NCT05484180 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: training and counseling supported guided imagery application
Description: After the preparation process, as a nursing attempt to the individuals in the experimental group; Training and consultancy supported guided imagery based on the health promotion model will be implemented. This initiative; It will take a total of 12 weeks, including 6 weeks of training program and 6 weeks of counseling program and guided imagery.
Study NCT05444010 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mandala painting
Description: nurse painted mandala for relaksing
Study NCT06395545 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electronic injector
Description: At room temperature, 1% lidocaine combined with 1:100,000 epinephrine was used as a local anesthesia. The electronic constant-speed injector, i-JECT® (MediHub Inc., Gyeonggi-do, Korea) (Figure 1) was used, and the injection speed of the injector was set at level 1 (0.25 mL/s) or level 2 (0.4 mL/s). The injection site in a patient was divided into two sides (left and right). The method of local infiltration (manual or using the electronic injector) was randomly assigned to each side of the surgical field, and 2.5 cc (0.5 cc at five separate areas) of local anesthetic was injected individually using a 5 cc syringe with a 31-gauge needle. All injections were administered by a single surgeon (Sung Joo Tommy Hwang) to reduce inter-operator variation.
Study NCT04779125 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Gluteus plasty enhanced with Progrip self gripping mesh
Description: Intervention group will be compared to historical patients in a case-control setting. Intervention group will have a mesh enhanced gluteus plasty made to reconstruct perineum after abdominoperineal resection.
Study NCT06264414 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DTT106
Description: oral route
Study NCT06264414 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dutasteride-Tamsulosin
Description: oral route
Study NCT05947175 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Vertebral bone marrow (vBMA) clot
Description: The clotted vBMA will be obtained from vertebral bone marrow aspirate.The vBMA clot contain mesenchymal stem cells (MSCs), growth factors, platelet and osteogenic and anti-inflammatory mediators.
Study NCT05947175 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Bone allograft chips
Description: Bone allograft chips will be obtained from Musculoskeletal Tissue Bank at IRCCS Istituto Ortopedico Rizzoli.
Study NCT06438068 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Modern Colon Hydrotherapy plus probiotic product intake
Description: Colonic cleansing through 3 interventions of Modern Colon Hydrotherapy separated by 48 hours. In addition, a daily intake of a product with prebiotic and prebiotic properties for 30 days.
Study NCT06438068 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Modern Colon Hydrotherapy plus probiotic product intake
Description: Colonic cleansing through 3 interventions of Modern Colon Hydrotherapy separated by 48 hours. In addition, a daily intake of a product with prebiotic and prebiotic properties for 30 days.
Study NCT04965129 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Drug: Placebo olive oil pill manufactured to mimic fish oil. Other Names: • Placebo
Study NCT04965129 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fish oil
Description: All subjects will be given fish oil with a dose of of 2.100 mg of EPA and 924 mg of DHA, in four tablet twice daily for four mounths.
Study NCT04581733 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MT1621
Description: All patients will receive MT1621 up to a target dose of 400 mg/kg/day each dC and dT, as tolerated.
Study NCT05237453 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Photons
Description: MR-guided adaptive radiotherapy
Study NCT06603558 — intervention group
Intervention type: DRUG
Intervention: Atogepant
Description: Oral Tablet
Study NCT04930965 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Community health worker engagement
Description: 3-4 in-person or virtual engagements (individual or group sessions) over 1 month, each engagement lasting 30 minutes to 1 hour
Study NCT06293677 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dosage Adjustment Rules for Augmented Renal Clearance (DAR-ARC) for piperacillin-tazobactam and meropenem
Description: Meropenem dosages according to eGFR \[mL/min/1.73 m²\] :~eGFR 120-149 : 40 mg/kg q6 h eGFR 150-199 : 30 mg/kg q4h eGFR 200-299 : 40 mg/kg q4h eGFR \&amp;gt;/= 300 : 40 mg/kg q4h~Piperacillin-tazobatam dosages according to eGFR \[mL/min/1.73 m²\] :~eGFR 120-149 : 150 mg/kg q6 h eGFR 150-199 : 120 mg/kg q4h eGFR 200-299 : 150 mg/kg q4h eGFR \&amp;gt;/= 300 : 180 mg/kg q4h~The maximum doses for the antibiotic prescription before the first drug monitoring will be 2gr of MER every 4 hours and 4gr of PIP every 4 hours.~The duration of infusion will be set to 2 h.
Study NCT06293677 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard dosages of piperacillin-tazobactam or meropenem
Description: Meropenem dosages according to eGFR \[mL/min/1.73 m²\] :~eGFR> 50 : 40mg/kg q8h eGFR 25-49 : 40mg/kg q12h eGFR 15-24 : 20mg/kg q12h~Piperacillin-tazobactam :~eGFR >50 : 100mg/kg q6h eGFR 20-49 : 50mg/kg q6h eGFR 15-29 : 50 mg/kg q8h
Study NCT05364229 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: MR-guided Radiotherapy Boost
Description: IMRT/VMAT prostate whole gland SBRT to 30 Gy in 5 fractions. MRL focal boost of 15 Gy in 1 fraction will be delivered either before or after whole gland SBRT.
Study NCT05449509 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Abdominal aortic Duplex ultrasound
Description: All patients will undergo bedside Duplex ultrasound in order to measure infrarenal abdominal aortic diameter.
Study NCT05678946 — intervention group
Intervention type: OTHER
Intervention: Integrated face-to-face rehabilitation and telerehabilitation
Description: Kela´s integrated face-to-face rehabilitation and telerehabilitation services for family caregivers include two 5-day periods of face-to-face rehabilitation and a 12-week telerehabilitation period between them. It is for those over the age of 18 who work as family caregivers on a daily basis and need support, tools, and coaching to understand and overcome the challenges posed by the care situation. Individual goals based on the GAS method are set, evaluated, and adjusted during the rehabilitation. The service, provided free of charge, is carried out in a Finnish rehabilitation centre and online over a period of 8 months, and it is implemented by a multidisciplinary team of rehabilitation experts. During the 12-week telerehabilitation period, the service providers utilise The Own Path, an acceptance and commitment therapy -based guided web intervention found beneficial for older Finnish family caregivers (Lappalainen et al. 2021). Telerehabilitation is independent of time and place.
Study NCT05678946 — intervention group
Intervention type: OTHER
Intervention: Social Holidays
Description: MTLH's Social Holidays for family caregivers are 5-day holidays in a Finnish hotel, spa, sports institute, or rehabilitation centre. The theme, content, and level of available assistance in Social Holidays vary, and the rehabilitation concept is lighter than that of Kela's rehabilitation services. Social Holidays include full-board accommodation and holiday activities, e.g. lectures, group discussions, instructed exercise, and a pampering treatment. MTLH organises Social Holidays for family caregivers as well as family caregivers and care recipients. The participants cover their travel expenses and pay a fixed sum of €125. Other than that, Social Holidays are provided free of charge. Social Holidays are intended for family caregivers who need recreational activities, rest, and peer support.
Study NCT05678946 — intervention group
Intervention type: OTHER
Intervention: Face-to-face rehabilitation
Description: Kela's rehabilitation services for family caregivers and the care recipients include three 5-day periods of face-to-face rehabilitation, which are carried out in a Finnish rehabilitation centre over a 10-month period and implemented by a multidisciplinary team of rehabilitation experts. The rehabilitation services for family caregivers and the care recipients are provided free of charge. The service is intended for persons over the age of 18 who work as family caregivers on a daily basis with or without family caregiver support and who need support, tools, and coaching to understand and overcome the challenges posed by the care situation. Individual goals based on the GAS method are set, evaluated, and adjusted during the rehabilitation.
Study NCT06663449 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: subcostal transversus abdominis plane block
Description: subcostal transversus abdominis plane block will be performed using 20 mL of 0.25 bupivacaine
Study NCT06663449 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: erector spinae plane block
Description: erector spinae plane block will be performed using 20 mL of 0.25 bupivacaine
Study NCT06591780 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinical Evaluation
Description: A clinical evaluation occurs at the first study session. The clinical evaluation assesses walking function and mobility, lower extremity, sensation, health-related quality of life (HRQoL) and foot function.~Session 2 will be a dynamometer-based evaluation of passive ankle stiffness and a 3-dimensional gait analysis to evaluate baseline biomechanics. During Session 3, real-time biofeedback conditions will be used to measure the immediate effects on walking function.
Study NCT06591780 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Plantar Pressure Biofeedback Gait Training
Description: Participants will complete a 3-dimensional gait evaluation prior to training, after a 6-minute control bout without biofeedback, and following three 6-minute biofeedback training bouts (total 18-minutes). Individualized biofeedback targets will be calculated from each participant's immediate biofeedback session to best minimize plantar pressure whilst maintaining or enhancing propulsion. Audio-visual biofeedback is provided using a screen placed in front of the treadmill and a speaker. For plantar pressure biofeedback, a visual display of a foot with a colored heat map represents the current plantar pressure, in addition to bar graphs representing real-time movement of plantar pressure in specific areas of the foot. A target is provided using the heat map colors of red and target line on the bar graph. Participants are informed that the target is a measurement of the pressure under their foot, and their goal is to decrease pressure to achieve their target
Study NCT06591780 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Propulsion Biofeedback Gait Training
Description: Participants will complete a 3-dimensional gait evaluation prior to training, after a 6-minute control bout without biofeedback, and following three 6-minute biofeedback training bouts (total 18-minutes). Individualized biofeedback targets will be calculated from each participant\&#39;s immediate biofeedback session to best minimize plantar pressure whilst maintaining or enhancing propulsion. Audio-visual biofeedback is provided using a screen placed in front of the treadmill and a speaker. For propulsion biofeedback, a visual display with a marker represents the current propulsion (peak AGRF) and a target provided to modulate propulsion. Participants are informed that the marker is a measurement of how hard they are pushing the ground backward, and their goal is to push-off more to achieve their target.
Study NCT06333548 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Appropriate for gestational age , small for gestational age, large for gestational age, Baby of mother diagnosed with GDM
Description: No intervention
Study NCT05710952 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Review by Modjaw
Description: A review by Modjaw's will be done before the braces treatment and after.
Study NCT05587803 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Neurowave and Sedline indices in view
Description: 3 additional electrodes are attached on the patients forehead. After electrode placement, the indices of both the SEDLINE device and the NEUROWAVE device are noted every 5 seconds for 1 minute
Study NCT04728399 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Experimental group
Description: Take 1 bag a day with warm boiling water. Intervention: 2g Soybean peptide, 3g CLA and ng protein. They will complete all baseline, 12-weeks, and 24-weeks visits
Study NCT04728399 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Control group
Description: Take 1 bag a day with warm boiling water. Intervention: 2g+N protein and 3g Soybean oil. They will complete all baseline, 12-weeks, and 24-weeks visits
Study NCT06552338 — intervention group
Intervention type: OTHER
Intervention: Observational
Description: No intervention. Study is observational
Study NCT02463305 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Creatine monohydrate
Description: 21 grams creatine monohydrate total per day
Study NCT06433518 — intervention group
Intervention type: DRUG
Intervention: recombinant hCG
Description: Experimental Group: Final oocyte triggering will be performed when the follicle or follicles measure between 13-16 mm.~Control Group: Final oocyte triggering will be performed when the follicle or follicles measure greater than 17 mm.~All triggers will be administered uniformly with 6500 units of recombinant hCG and 0,2 mg triptorelin injections.~The primary outcome of the study will be the number of mature oocytes. Secondary outcomes will include fertilization rates, embryo counts, and implantation rates.~Primary and secondary outcomes will be compared between the two groups.
Study NCT02463305 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 7 grams of dextrose dissolved in 500mL water, taken three times daily
Study NCT06222541 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nudges in Web-Based Supermarket
Description: While shopping in the web-based supermarket, participants assigned to the nudge arm will see retail nudges to discourage sugary drink purchases and promote healthier substitutes.
Study NCT04792359 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Equinometer
Description: Measurement of dorsiflexion of the ankle will be reproduced three times on each ankle in two positions, with a force applied
Study NCT05322837 — intervention group
Intervention type: OTHER
Intervention: Clinical and technological-aided assessments and questionnaires
Description: Assessments and questionnaires related to upper limb function and quality of life will be used
Study NCT06238752 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apatinib Combined With Tislelizumab and Chemotherapy
Description: apatinib (250 mg, qd, d1-14), tislelizumab(200 mg d1), and oxaliplatin (130 mg/m2, d1) plus oral capecitabine (1000 mg/m2, bid, d1-14) every 3 weeks
Study NCT05075213 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: contingency management (deposit contract)
Description: Participants will deposit $30 of their own money to play QuitBet. Participants will submit a CO test once per day between the hours of noon and 11:59pm. Participants whose CO test is 6ppm or lower (indicating no smoking) on at least 24 of 26 days between day 3-28 of the game will be declared winners and split the pot of deposited money. Participants who submit at least 21 CO tests, regardless of the result, will be entered into a raffle to win a prize worth $75.
Study NCT05075213 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: contingency management (deposit contract)
Description: Participants will deposit $30 of their own money to play QuitBet. Participants will submit a CO test once per day between the hours of noon and 11:59pm. Participants whose CO test is 6ppm or lower (indicating no smoking) on at least 24 of 26 days between day 3-28 of the game will be declared winners and split the pot of deposited money. Participants who submit at least 21 CO tests, regardless of the result, will be entered into a raffle to win a prize worth $75.
Study NCT05075213 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: leaderboard and social feed
Description: Participants will have access to a discussion board on which participants can post and respond to messages to each other. Also, a game host will post educational information about smoking cessation and serve as a discussion moderator.
Study NCT05075213 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: smoking cessation resource list
Description: Participants will have access to a list of smoking cessation resources
Study NCT05506436 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Evident 3
Description: It consists of brief 5-minute counselling on general physical activity recommendations and explaining the plate method for a balanced diet. Also, it includes the Evident 3 application, which is a daily dietary log that provides information on calories and diet composition and shows a reminder of the 10000 steps/day.
Study NCT05506436 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Evident 3
Description: It consists of brief 5-minute counselling on general physical activity recommendations and explaining the plate method for a balanced diet. Also, it includes the Evident 3 application, which is a daily dietary log that provides information on calories and diet composition and shows a reminder of the 10000 steps/day.
Study NCT05506436 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Implementation strategy
Description: Four sessions have been designed to obtain the implementation strategy:~First session: Presentation of the Evident 3 application and its results in clinical trials. Training in the use of the application and identification of possible areas for improvement.~Second session: Presentation of evidence-based practices on the management of obesity in Primary Care. Consensus selection of those related to health promotion and mHealth. Sharing of possible lines of improvement of the care offered in the practice.~Third session (optional): Intervention on those components (coherence, cognitive participation, collective action and reflective follow-up) of the NOMAD questionnaire, if very low scores are obtained.~Fourth session: Brainstorming on possible strategies for the implementation of the Evident 3 intervention. Analysis and evaluation of these strategies and determination of a common strategy for their implementation.